Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Apr 23, 2015 (11 years ago)

Meloxicam capsules

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Penicillin Cross Contamination: Multiple finished products potentially contaminated with penicillin.

Cause type: Cross-contamination

Traces of another drug - most often penicillin - got into the product from shared equipment or facilities. Even trace penicillin can trigger a severe allergic reaction in someone who was never meant to receive it. All cross-contamination recalls.

What was recalled

Meloxicam capsules, 12 mg, Rx Only, Manufactured by Park Compounding, Irving, CA -non-sterile formulation

Drug: Meloxicam Category: Pain Relief & OTC Medication

Recalling firm
South Coast Specialty Compounding, Inc.
Origin
CA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1339-2015 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Meloxicam recalls

See all
Class III · Low risk

Zynrelef (bupivacaine and meloxicam)

Defective Delivery System: An incorrect 10 mL (12 mL) Luer (slip) syringe packaged in one lot of Zynrelef 400 mg/12 mg kit

Terminated Packaging defect Heron Therapeutics, INC. NDC 47426-301-02 D-1335-2022
Class II · Moderate risk

Meloxicam Tablets

CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

Terminated Temperature excursion Cardinal Healthcare D-0190-2024
Class II · Moderate risk

Meloxicam Tablets

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. NDC 69097-158-07 D-0463-2021
Class III · Low risk

Mobic (meloxicam)

Labeling: Incorrect or missing package insert. One lot of Mobic Tablets is packaged with an incorrect insert.

Terminated Labeling / mix-up Boehringer Ingelheim Pharmaceuticals, Inc. NDC 0597-0030-01 D-0007-2018
Class II · Moderate risk

All lidocaine

Lack of Processing Controls

Terminated cGMP deviation Reliable Rexall-A Compounding Pharmacy D-1103-2016

Other recalls by South Coast Specialty Compounding, Inc.

All 2015 recalls
Class II · Moderate risk

Bi-Est (estriol,estradiol)

Penicillin Cross Contamination: Multiple finished products potentially contaminated with penicillin.

Terminated Cross-contamination South Coast Specialty Compounding, Inc. D-1415-2015
Class II · Moderate risk

Bi-Est (estriol,estradiol)

Penicillin Cross Contamination: Multiple finished products potentially contaminated with penicillin.

Terminated Cross-contamination South Coast Specialty Compounding, Inc. D-1414-2015
Class II · Moderate risk

Estradiol cream

Penicillin Cross Contamination: Multiple finished products potentially contaminated with penicillin.

Terminated Cross-contamination South Coast Specialty Compounding, Inc. D-1413-2015
Class II · Moderate risk

Bi-Est (estriol,estradiol)

Penicillin Cross Contamination: Multiple finished products potentially contaminated with penicillin.

Terminated Cross-contamination South Coast Specialty Compounding, Inc. D-1412-2015